Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Rosiptor (AQX-1125) (AQX-1125) is an orally-active and specific phosphatase SHIP1 activator with anti-inflammatory effects.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 113.00 | |
5 mg | In stock | $ 289.00 | |
10 mg | In stock | $ 396.00 | |
25 mg | In stock | $ 648.00 | |
50 mg | In stock | $ 912.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 318.00 |
Description | Rosiptor (AQX-1125) (AQX-1125) is an orally-active and specific phosphatase SHIP1 activator with anti-inflammatory effects. |
In vitro | In MOLT-4 but not Jurkat cells, Rosiptor (0.1-10 μM, 30 minutes) inhibits Akt activation [1]. |
In vivo | Rosiptor (10 mg/kg, p.o.) has the Cmax value of 0.830 μM and the t1/2 value of 5.2 hours. AQX-1125 also exhibits >80% oral bioavailability [1]. Rosiptor (3-30 mg/kg, p.o., daily for 3 days) significantly reduces the total number of BAL leukocytes in NSC-125066-challenged mice and reduces MPO activity [2]. |
Cell Research | Cell Line: MOLT-4 cells and SHIP1-deficient Jurkat cells (IGF-1 stimulation) [1]. Concentration: 0.1, 1, 10 μM. Incubation Time: 30 minutes |
Animal Research | Animal Model: 6-8 weeks old male CD-1 mice[1]. Dosage: 3, 10, 30 mg/kg. Administration: p.o., daily for 3 days |
Synonyms | AQX-1125 |
Molecular Weight | 321.5 |
Formula | C20H35NO2 |
CAS No. | 782487-28-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 145 mg/mL (451 mM), Sonification and heating are recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Rosiptor 782487-28-9 Metabolism Phosphatase AQX1125 AQX-1125 Inhibitor AQX 1125 inhibit inhibitor